Deployment and Evaluation of Humanoid Robotics in Coalition-Aligned Clinical Care Settings (HEALTH)

Truway Health, Inc.

Status and phase: Invitation-only; Phase 2

Conditions: Sanitation Protocol Compliance; Mobility Impairment; ESG-linked Healthcare Robotics Deployment; Clinical Workflow Optimization

Treatments: Behavioral: ESG Compliance Monitoring, Operational protocol; Biological: Skin Cell Dip; Biological: Stem Cell Dip; Other: Wage Token Distribution

Study type: Interventional

Funder types: Industry

Identifiers

NCT07214896

TRU-HUM-CLIN-2025-PRS

Details and patient eligibility

About

This clinical trial evaluates the deployment of humanoid robotics in coalition-aligned healthcare settings. The study measures biometric performance, ESG compliance, and operational impact across patient care, sanitation, and intake workflows. Humanoid units are enhanced via biotech integration and compensated through blockchain-based wage tokens. Outcomes will inform coalition governance, wage calibration, and metro-scale deployment strategies.

Full description

The HEALTH trial (Humanoid Evaluation and Learning Trial in Healthcare) is a coalition-aligned clinical study designed to assess the deployment of humanoid robotics in real-world care environments. Conducted across metro facilities in New York, Austin, Frankfurt, and Tokyo, the trial evaluates robotic performance in patient intake, sanitation, mobility assistance, and ESG-linked operations.

Humanoid units are enhanced through biotech integration, including skin cell regeneration dips and stem cell neural augmentation. Each unit is tracked via biometric audit scoring across five dimensions: motor function, cognitive response, ESG compliance, biotech retention, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard.

Wage tokens (HumanoidWage, HMW) are minted based on performance thresholds and distributed through smart contracts to deployed units. FX arbitrage across Tokyo and Frankfurt informs reinvestment logic and 1031 exchange-backed yield farming pools. DAO voting governs deployment, wage calibration, and protocol expansion.

This trial aims to establish scalable, transparent frameworks for humanoid integration in healthcare, anchored in coalition governance, public oversight, and metro-ready infrastructure.

Enrollment: 400 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

- Age 18-75 years

Able to provide informed consent

Facility staff, clinical auditors, ESG observers, or coalition stakeholders

Willing to interact with humanoid robotics in clinical workflows

Available for biometric feedback and observational logging over 90 days

Exclusion criteria

- Cognitive impairment preventing informed consent

Active infectious disease requiring isolation

Prior adverse reaction to biotech-enhanced robotics

Involvement in conflicting clinical trials

Inability to comply with protocol procedures or coalition transparency requirements

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

400 participants in 4 patient groups

New York Facility - Skin Cell Deployment

Experimental group

Description:

Humanoid units deployed in patient intake and sanitation roles. Enhanced with keratinocyte-based skin cell dips to improve tactile sensitivity and surface regeneration. Assigned Roles: Intake assistant, sanitation technician Biometric Focus: Motor function, ESG compliance

Treatment:

Biological: Skin Cell Dip

Austin Facility - Stem Cell Cognitive Enhancement

Experimental group

Description:

Humanoid units deployed in mobility and R\&D support roles. Enhanced with iPSC-derived stem cell dips targeting neural responsiveness and adaptive learning. Assigned Roles: Mobility assistant, lab technician Biometric Focus: Cognitive response, biotech retention

Treatment:

Biological: Stem Cell Dip

Frankfurt Facility - ESG Optimization

Experimental group

Description:

Humanoid units deployed in ESG-linked sanitation and logistics roles. Monitored for energy usage, carbon offset, and protocol adherence. Assigned Roles: ESG sanitation, logistics handler Biometric Focus: ESG compliance, human interaction

Treatment:

Behavioral: ESG Compliance Monitoring, Operational protocol

Tokyo Facility - Wage Token Calibration

Experimental group

Description:

Humanoid units deployed in public interface and intake roles. Wage tokens minted based on biometric audit scores and task completion. Assigned Roles: Receptionist, intake coordinator Biometric Focus: Wage token distribution, interaction scoring

Treatment:

Other: Wage Token Distribution